Medical tourism startup CureMeAbroad has raised $1.1 million to expand its global healthcare platform, reported on 7 October 2026. The startup connects international patients with accredited hospitals, targeting an ambitious jump from its current $4.8 million annual treatment-booking run rate to $100 million by FY2028.
The company currently records more than 22,500 monthly visitors and has partnerships with over 400 accredited hospitals across six countries. It has received Medical Travel Facilitator Certification from Global Healthcare Accreditation (GHA), positioning it in the certified tier of a market crowded with unverified facilitators.
Its primary patient-acquisition markets are the US, UK, Australia and Canada — countries where demand for international treatment options keeps rising as elective-care costs climb at home. It competes globally with Bookimed, PlacidWay and Medical Departures, and in India with medical tourism facilitator Vaidam Health.
The ambition is steep — a ~20x jump in bookings in two years — but the India cost-advantage story for procedures from orthopaedics to wellness retreats keeps pulling volume.
Why it matters for founders
Medical tourism is one of the few Indian consumer plays with genuinely global demand and hard cost arbitrage. CureMeAbroad's GHA certification shows how trust signals — not just price — win the international patient. Build the accreditation before you scale the funnel.
Find these funders and apply in one click — browse investor profiles at /investors and prepare your application with the /apply-kit.